Cargando…
Preclinical Therapeutic Potential of a Nitrosylating Agent in the Treatment of Ovarian Cancer
This study examines the role of s-nitrosylation in the growth of ovarian cancer using cell culture based and in vivo approaches. Using the nitrosylating agent, S-nitrosoglutathione (GSNO), a physiological nitric oxide molecule, we show that GSNO treatment inhibited proliferation of chemoresponsive a...
Autores principales: | Giri, Shailendra, Rattan, Ramandeep, Deshpande, Mandar, Maguire, Jacie L., Johnson, Zachary, Graham, Rondell P., Shridhar, Viji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041717/ https://www.ncbi.nlm.nih.gov/pubmed/24887420 http://dx.doi.org/10.1371/journal.pone.0097897 |
Ejemplares similares
-
Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer
por: Giri, Shailendra, et al.
Publicado: (2013) -
Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer
por: Hijaz, Miriana, et al.
Publicado: (2016) -
Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner
por: Rattan, R, et al.
Publicado: (2011) -
Metformin limits the adipocyte tumor-promoting effect on ovarian cancer
por: Tebbe, Calvin, et al.
Publicado: (2014) -
Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
por: Dar, Sajad, et al.
Publicado: (2017)